Comparing the attitudes of physicians and non-physicians toward communicating a patient’s BRCA1 mutation to a first-degree relative against a patient’s wishes

• Published in: Journal of community genetics 2022-08, Vol.13 (4), p.403-410
• Main Authors: Zebrack, Jane E., Yang, Wei, Milone, Matthew, Coppes, Max J.
• Format: Article
• Language: English
• Subjects: Biomedical and Life Sciences; Biomedicine; BRCA1 protein; Epidemiology; Familiarity; Gene Function; Gene Therapy; Genetic screening; Genetic testing; Human Genetics; Mutation; Original; Original Article; Patients; Physicians; Public Health; Qualitative research
• ISSN: 1868-310X; 1868-6001
• DOI: 10.1007/s12687-022-00591-2

Although genetic testing can be vastly informative, it creates a dilemma if a patient does not want to disclose an abnormal genetic test to at-risk relatives. A sample of 200 participants from Nevada (100 physicians, 100 non-physicians) completed an 11-item questionnaire asking demographic information, familiarity with genetics and genetic testing, and opinions about a physician’s role in a hypothetical case in which a patient does not wish to communicate her BRCA1 mutation to her sister. Although most respondents did not think the physician should notify the sister against the patient’s wishes, more non-physicians (40%) than physicians (23%) contended that the physician should do so ( p  = 0.0119). Most respondents from both groups agreed that the physician should not have the legal duty to notify the sister, would not be morally justified in sharing genetic test results with the sister, but should have the right to notify a patient’s relatives if the disease is “serious, preventable, and treatable.” More non-physicians than physicians agreed that physicians should have an educational requirement on how to communicate genetic test results to patients and their family (88% vs 65%, p  = 0.0002). Most physicians (70%) reported a familiarity/strong familiarity with genetic testing compared to non-physicians (33%; p